<DOC>
	<DOCNO>NCT00494832</DOCNO>
	<brief_summary>The purpose study : 1 . To evaluate safety efficacy Dexmedetomidine adjunct anesthesia spine surgery 2 . To investigate influence Dexmedetomidine evoke potential .</brief_summary>
	<brief_title>Influence Dexmedetomidine Evoked Potentials During Spine Surgery</brief_title>
	<detailed_description>Use evoke potential significantly improve neurologic outcome major spine surgery . Modalities evoke potential commonly use Somato-Sensory Evoked Potentials ( SSEP 's ) , Motor Evoked Potentials ( MEP 's ) , Visual Evoked Potentials ( VEP 's ) . Dexmedetomidine ( DEX ) alpha-2 agonist FDA approve adjunct sedative agent general anesthesia . It purport reduce amount anesthetic require potentiate analgesic effect opiate . In addition , DEX show minimal effect SSEP 's VEP 's rat human . Any decrease dose general anesthesia improve monitor evoked potential , support DEX adjunct . It known anesthetic agent interfere record evoke potential . The choice anesthetic however , depend modality neurophysiologic monitoring plan patient . Total intravenous anesthesia ( TIVA ) Sevoflurane , low dose inhalational anesthetic usual agent spine surgery . Both dose-related depressant effect quality evoke potential . As result , common practice anesthesiologist adjust depth anesthesia improve signaling . The use either anesthetic must accompany continuous infusion Propofol opioid , Remifentanil Fentanyl . The anesthesiologist decide whether DEX adjunct . In experience , DEX impair evoke potential . In fact , improve quality signal patient . Yet , publish data effect medical literature . We hypothesize Dexmedetomidine influence evoke potential use adjunct general anesthesia . Our study prospective , randomize , double-blinded carry set anesthetic . We first evaluate DEX adjunct TIVA , adjunct Sevoflurane . The probable benefit DEX may avoid use potent inhaled anesthetic would improve VEP 's monitoring . Quality record evoked potential enhance ability detect iatrogenic injury spinal cord vision .</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Adult spine surgery patient require evoked potential monitor . Age young 18 old 80 year Patients moderate neurological deficit ASA grade 3 Any chronic psychiatric disorder Body mass index ( BMI ) 35 Patients cortical blindness , cataract , retinal optic neuropathy , glaucoma , untreated diabetes , active hepatitis , active coronary artery disease , untreated arrhythmia patient renal hepatic insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Evoked potential</keyword>
	<keyword>Spine surgery</keyword>
</DOC>